Jyothi U. Menon’s Research Profile

Menon, Jyothi, 2021

  • Associte Professor
  • Chemical Engineering / Biomedical and Pharmaceutical Sciences
  • Phone:401.874.4914
  • Email:jmenon@uri.edu
  • Office Location: Fascitelli Center for Advanced Engineering 310

Recent Publications1

Citation
Gonsalves A, Sorkhdini P, Bazinet J, et al. Development and characterization of lung surfactant-coated polymer nanoparticles. Biomaterials Advances, 2023; 150, 213430. doi: 10.1016/j.bioadv.2023.213430
Hemme L C, Carley R, Norton A, et al. Developing virtual and augmented reality applications for science, technology, engineering and math education. Biotechniques, 2023. doi: 10.2144/btn-0029
Perera K, Nguyen DX, Wang D. Biodegradable and Inherently Fluorescent pH-Responsive Nanoparticles for Cancer Drug Delivery. Pharmaceutical Research, 2022, doi: 10.1007/s11095-022-03317-8
Gonsalves A, Tambe P, Le DQ, et al. Synthesis and Characterization of a Novel pH-Responsive Drug-Releasing Nanocomposite Hydrogel for Skin Cancer Therapy and Wound Healing. Journal of Materials Chemistry B, 2021. doi: 10.1039/D1TB01934A
Perera K, Ivone R, Natekin E, Wilga CA, Shen J, Menon J. 3D Bioprinted Implants for Cartilage Repair in Intervertebral Discs and Knee Menisci. Frontiers in Bioengineering and Biotechnology, 2021. doi: 10.3389/fbioe.2021.754113
Dhamecha D, Le D, Chakravarty T, et al. Fabrication of PNIPAm-based thermoresponsive hydrogel microwell arrays for tumor spheroid formation. Materials Science and Engineering: C, 2021; 125, 112100. doi: 10.1016/j.msec.2021.112100
Ghumman M, Dhamecha D, Gonsalves A, et al. Emerging Drug Delivery Strategies for Idiopathic Pulmonary Fibrosis Treatment. European Journal of Pharmaceutics and Biopharmaceutics, 2021; 164, 1-12. doi: 10.1016/j.ejpb.2021.03.017
Bhushan A, Gonsalves A, Menon JU. Current State of Breast Cancer Diagnosis, Treatment, and Theranostics. Pharmaceutics, 2021; 13(5), 723. doi: 10.3390/pharmaceutics13050723
Ramasamy S, Dhamecha D, Kaliyamoorthi K, et al. Magnetic hydroxyapatite nanomaterial-cyclodextrin tethered polymer hybrids as anticancer drug carriers. Materials Advances, 2021; 2(10), 3315-3327. doi: 10.1039/D1MA00142F
Dhamecha D, Le D, Movsas R, Gonsalves A, Menon JU. Porous polymeric microspheres with controllable pore diameters for tissue engineered lung tumor model development. Frontiers in Bioengineering and Biotechnology, 2020; 8, 799. doi: 10.3389/fbioe.2020.00799
Owen J, Thomas E, Menon J, et al. Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. Journal of Controlled Release, 2020; 319, 222-233. doi: 10.1016/j.conrel.2019.12.045
Le D, Dhamecha D, Gonsalves A, Menon JU. Ultrasound-enhanced chemiluminescence for bioimaging. Frontiers in Bioengineering and Biotechnology, 2020; 8, 25. doi: 10.3389/fbioe.2020.00025
Pandey N, Menon JU, Takahashi M, et al. Thermo-responsive Fluorescent Nanoparticles for Multimodal Imaging and Treatment of Cancers. Nanotheranostics, 2020; 4(1), 1-13. doi: 10.7150/ntno.39810
Dhamecha D, Movsas R, Sano U, Menon JU. Applications of alginate microspheres in therapeutics delivery and cell culture: Past, present and future. International Journal of Pharmaceutics, 2019; 569, 118627. doi: 10.1016/j.ijpharm.2019/118627
Gill MR, Menon JU, Carlisle R, Vallis KA. Combining ruthenium metallo-intercalators and targeted radionuclide therapy for EGFR-overexpressing oesophageal cancer. Cancer Research, 2019; 79(13), 994-994. doi: 10.1158/1537-7445.AM2019-994
Kuriakose AE, Hu W, Nguyen KT, Menon JU. Scaffold-based lung tumor culture on porous PLGA microparticle substrates. PLoS One, 2019; 14(5), 217640. doi: 10.1371/journal.pone.0217640
Dane DM, Yilmaz C, Gyawali D, et al. Erythropoietin inhalation enhances adult canine alveolar-capillary formation following pneumonectomy. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2019; 316(5), 936-935. doi: 10.1152/ajplung.00504.2018
Thomas E, Menon J, Owen J, et al. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy. Theranostics, 2019; 9(19), 5595-5609. doi: 10.7150/thno.34669
Owen J, Menon J, Gray M, et al. PO-116 Indium-111 afterloading of preformed EGF-containing liposomes for molecularly targeted radionuclide delivery via ultrasound-induced cavitation. ESMO Open, 2018; 3(2), A271. doi: 10.1136/esmoopen-2018-EACR25.641
Menon JU. 3D Tumor Models for Cancer Drug Discovery: Current Status and Outlook. Journal of Medicine and Therapeutics, 2018; 2(3), 1-2. doi: 10.15761/JMT.1000137
Gill MR, Menon JU, Jarman PJ, et al. 111 In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells. Nanoscale, 2018; 10(22), 10596-10608. doi: 10.1039/C7NR09606B

 

1view our research page criteria